IRIS
LIGUORI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.674
EU - Europa 926
AS - Asia 336
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
AF - Africa 2
Totale 12.960
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.650
IE - Irlanda 286
IT - Italia 215
CN - Cina 157
KR - Corea 123
DE - Germania 93
GB - Regno Unito 83
UA - Ucraina 82
FR - Francia 39
SE - Svezia 38
RU - Federazione Russa 26
CA - Canada 24
FI - Finlandia 18
BE - Belgio 14
IN - India 14
NL - Olanda 11
BR - Brasile 6
JP - Giappone 6
PL - Polonia 6
CH - Svizzera 5
HK - Hong Kong 5
SG - Singapore 5
AU - Australia 4
EU - Europa 4
PH - Filippine 4
CL - Cile 3
HU - Ungheria 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DK - Danimarca 2
EG - Egitto 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 12.960
Salva come PNG Salva come JPEG
Città #
Wilmington 3.425
Houston 3.114
Woodbridge 1.695
Fairfield 645
Chandler 460
Ashburn 358
Cambridge 259
Seattle 257
Dublin 244
Ann Arbor 182
Medford 180
New York 117
Rome 100
Lawrence 86
Beijing 84
Dearborn 75
San Diego 61
Menlo Park 50
Seoul 30
Jacksonville 29
Redwood City 25
London 22
Norwalk 22
Durham 19
Toronto 18
Milan 16
Kilburn 15
Brussels 14
Nanjing 14
Philadelphia 14
Creede 13
Zhengzhou 12
Pune 11
San Jose 11
Palo Alto 10
Shanghai 9
Atlanta 7
San Francisco 7
Boardman 6
Garden City 6
Mountain View 6
Phoenix 6
Amsterdam 5
Reggio Calabria 5
Shenzhen 5
Verona 5
Washington 5
Wuhan 5
Council Bluffs 4
Hefei 4
Helsinki 4
Huskvarna 4
Kunming 4
Los Angeles 4
Palermo 4
São Paulo 4
Budapest 3
Chengdu 3
Columbus 3
Esslingen am Neckar 3
Hounslow 3
Naples 3
Nashville 3
Redmond 3
Saint Petersburg 3
Singapore 3
Solofra 3
Sutton Coldfield 3
Tokyo 3
Walton on Thames 3
Warsaw 3
Alderley Edge 2
Apeldoorn 2
Augusta 2
Bangkok 2
Bologna 2
Capranica 2
Changsha 2
Colombo 2
Como 2
Doganella 2
Enfield 2
Ergolding 2
Falls Church 2
Guangzhou 2
Hong Kong 2
Islington 2
Kraków 2
La Veta 2
Lappeenranta 2
Las Vegas 2
Lucca 2
Manila 2
Melbourne 2
Nanchang 2
New Bedfont 2
Pisa 2
Porto Alegre 2
Prescot 2
Roebling 2
Totale 11.899
Salva come PNG Salva come JPEG
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 445
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 443
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 420
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 401
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 386
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 383
Catecholamine-based treatment in AD patients: expectations and delusions 360
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 352
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 334
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 334
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 330
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 322
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 320
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 316
Obstructive sleep apnoea and bone health 309
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 305
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 293
Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity 270
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 258
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 257
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 251
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 242
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study 239
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 238
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 234
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 210
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 207
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 185
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 185
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 177
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 175
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 174
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 172
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 171
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 160
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 155
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 149
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 145
Seasonality of restless legs syndrome: symptom variability in winter and summer times 144
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 140
Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment 136
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 132
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 127
Laterality of Auditory Dysfunction in Parkinson's Disease 115
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 108
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 104
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease 103
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 103
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 95
Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure 70
Is it time to consider obstructive sleep apnea syndrome a risk factor for Alzheimer's disease? 68
Increased noradrenaline as an additional cerebrospinal fluid biomarker in PSP-like parkinsonism 64
Acute care hospital at different levels of intensity: the role of Geriatrician 62
Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: a cerebrospinal fluid-based study 59
Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: A prospective study 58
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 58
The reverse metabolic syndrome in the elderly: Is it a “catabolic” syndrome? 55
Sarcopenia: Assessment of disease burden and strategies to improve outcomes 55
Physical Activity Scale for the Elderly (PASE) Score Is Related to Sarcopenia in Noninstitutionalized Older Adults 54
The Italian version of the “frailty index” based on deficits in health: a validation study 52
Risk of Malnutrition Evaluated by Mini Nutritional Assessment and Sarcopenia in Noninstitutionalized Elderly People 48
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 47
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 47
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 46
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 44
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect. 42
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 42
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 40
Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations 39
Sleep problems affect quality of life in Parkinson's disease along disease progression. 37
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 37
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 37
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 36
COVID-19: dealing with a potential risk factor for chronic neurological disorders 35
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 33
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 32
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 29
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 29
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 28
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 27
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 26
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 24
Sleep and wake impairment in patients with SARS-CoV2 infection 24
Obstructive sleep apnea, palatal morphology, and aortic dilatation in marfan syndrome growing subjects: A retrospective study 23
Subthalamic nucleus deep brain stimulation on motor-symptoms of Parkinson's disease: Focus on neurochemistry. 23
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 22
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up 20
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 18
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 17
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 15
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 15
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 14
The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer's Disease: A Special Focus on Cognitive Performance 13
Saliva Analysis of pH and Antioxidant Capacity in Adult Obstructive Sleep Apnea Patients 10
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 10
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 8
Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study 8
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort 8
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 8
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 7
Totale 13.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019877 0 0 0 0 0 0 0 0 0 272 304 301
2019/20203.961 250 243 188 303 276 315 296 471 521 421 336 341
2020/20213.249 373 349 367 358 342 387 388 298 59 143 123 62
2021/20221.112 41 65 46 31 18 46 219 25 51 81 72 417
2022/20231.245 142 118 49 132 109 254 116 98 115 20 51 41
2023/2024561 73 13 37 20 60 182 36 107 13 20 0 0
Totale 13.401